(Q43852088)

27 November 2017

Different factors influencing the expression of Raynaud's phenomenon in men and women (English)

1 reference

27 November 2017

2

1 reference

27 November 2017

8

1 reference

27 November 2017

7

Wilson PW

1 reference

27 November 2017

Fraenkel L

1

1 reference

27 November 2017

Chaisson CE

3

1 reference

27 November 2017

Maricq HR

4

1 reference

27 November 2017

Evans SR

5

1 reference

27 November 2017

Brand F

6

1 reference

27 November 2017

1 February 1999

1 reference

27 November 2017

Arthritis & Rheumatology

1 reference

27 November 2017

42

1 reference

27 November 2017

2

1 reference

27 November 2017

306-310

1 reference

Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients

27 November 2017

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

Sex differences in control of cutaneous blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

The framingham offspring study. Design and preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. The UK Scleroderma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

Prevalence of symptoms of Raynaud's phenomenon in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

Prevalence of primary Raynaud phenomena in young females

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

The acute effects of cigarette smoking on cutaneous blood flow in smoking and non-smoking subjects with and without Raynaud's phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

The Association of Estrogen Replacement Therapy and the Raynaud Phenomenon in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

Demographic, social and clinical correlates of Raynaud phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

Alcohol Intake and Bone Mineral Density in Elderly Men and Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

Prevalence of Raynaud's phenomenon in Japanese males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

Raynaud's phenomenon in a female population: prevalence and association with other conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199902%2942%3A2%3C306%3A%3AAID-ANR13%3E3.0.CO%3B2-G

10.1002/1529-0131(199902)42:2<306::AID-ANR13>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference